Highlights

Kossan- Riding strong on the Covid-19 train

Date: 22/05/2020

Source  :  BIMB
Stock  :  KOSSAN       Price Target  :  10.00      |      Price Call  :  BUY
        Last Price  :  6.08      |      Upside/Downside  :  +3.92 (64.47%)
 


  • Overview. 1QFY20 net profit increased to RM64.8m (+6.2% qoq, +10.4% yoy) mainly due to rise in sales volume (8.3% qoq, 7.4% yoy) and higher ASP (0.5% qoq, 2% yoy). Nitrile rubber raw material prices fell c.8% qoq, c.12% yoy. Consequently, EBITDA margin improved to 18.3% (+1.3 ppts qoq).
  • Key highlights. Kossan current utilization rate is at c.90% and order lead time increased to 9 months (vs 2-3 months normally). Kossan factory F19 (10 lines, 3bn pcs p.a.) currently has 8 lines operational and expect full commissioning by June. Upon full completion of F19, Kossan installed capacity will increase to 32bn pcs p.a (table 3).
  • Against estimates: Inline. 1QFY20 net profit was inline with our and consensus forecast at 24% and 23% respectively.
  • Outlook. A prolonged Covid-19 outbreak and concerns on virus resurgence as well as longer time taken for mass production of vaccine create impetus for greater restocking activities. Demand has been rising significantly since April, causing a supply shortage and driving prices higher. Kossan has seen ASP increased about c.4-5% recently and expect higher ASP in 2HFY20. As such, we raised our earnings forecast for FY20/21 by 26%/26% respectively as we increased sales and imputing higher ASP c.7%. We now expect profit margin to hold at 12.6% in FY20.
  • Our call. Maintain BUY with new TP of RM10.00 (from RM6.60) based on higher PER of 34x (which is c.10% discount to our glove sector forward PER) and pegged on revised FY21 EPS. We continue to like Kossan due to its strong prospect on the back of surge in demand from restocking activities and greater increase in ASP, hence expecting higher earnings growth of 51% yoy in FY20. Kossan currently trades at 30x our forward PER, of which the valuation looks more attractive compared to its peers Hartalega and Top Glove trading at our forward PER circa 53x and 36x respectively.
  • Upside risk. Stronger than expected increase in ASP and sudden weakness in MYR.

Source: BIMB Securities Research - 22 May 2020

Share this
Labels: KOSSAN

Related Stocks

Chart Stock Name Last Change Volume 
KOSSAN 6.08 -0.12 (1.94%) 1,330,000 

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

372  613  600  834 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 YONGTAI 0.355+0.06 
 MTRONIC 0.145+0.025 
 HWGB 0.95+0.105 
 MTRONIC-WA 0.095+0.02 
 SAPNRG 0.125+0.005 
 PHB 0.030.00 
 EAH 0.03-0.005 
 INIX 0.34+0.075 
 KNM 0.225+0.015 
 KANGER 0.1750.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Vivocom’s V-Shape Recovery still intact, and a sharp rally upwards to RM1.22/RM1.48/RM2.20 can take off anytime See Jovin
2. Vivocom’s Steady and Calm Rally to RM1.12 Today. Will It Surge to Break RM1.22 Soon? See Jovin
3. 商业高峰(PUNCAK,6807)股价低于产值 。。。。 jjjmoney
4. AN UNDISCOVERED GEM UPDATE: NEW HOT HOT SELLING PRODUCT FLYING OFF THE SHELVES !! Chongkh888
5. Shipping out VACCINE timely? Forwarders see their cargo bumped as vaccine shipments take off. gloveharicut
6. TOPGLOV hints HR ministry’s action does not match stated stand gloveharicut
7. Vivocom’s V-Shape Recovery still intact. Rally still ongoing in a calm and steady stair stepped ascension. See Jovin
8. CIMB Retain Add on TOPGLOV; awaiting further updates on Act 446 gloveharicut
PARTNERS & BROKERS